2020
Impact of breast cancer chemotherapy on ovarian damage and recovery.
Goldfarb S, Bedoschi G, Turan V, Crown A, Abdo N, Dickler M, Oktay K. Impact of breast cancer chemotherapy on ovarian damage and recovery. Journal Of Clinical Oncology 2020, 38: e24059-e24059. DOI: 10.1200/jco.2020.38.15_suppl.e24059.Peer-Reviewed Original ResearchAMH recoveryBreast cancerBaseline AMHOvarian reserveNon-metastatic breast cancerBaseline AMH levelsTime of diagnosisBreast cancer patientsBreast cancer chemotherapyImpact of chemoImportant predictorCancer ptsChemo groupGonadotoxic chemoChemotherapy regimenOvarian damageSerum AMHAMH levelsStudy entryTamoxifen treatmentFertility preservationLow AMHProspective studyCancer patientsFuture fertility
2014
A prospective longitudinal study of the impact of breast cancer chemotherapy on ovarian reserve: do individuals have differing susceptibilities?
Oktay K, Goldfarb S, Bedoschi G, Quistorff J, Grunblatt E, Cigler T, Moy F, Patil S, Goswami S, Dickler M. A prospective longitudinal study of the impact of breast cancer chemotherapy on ovarian reserve: do individuals have differing susceptibilities? Fertility And Sterility 2014, 102: e151. DOI: 10.1016/j.fertnstert.2014.07.517.Peer-Reviewed Original ResearchBreast cancer chemotherapyProspective longitudinal studyOvarian reserveCancer chemotherapyLongitudinal studyChemotherapy
2006
O-227 Impact of breast cancer chemotherapy on ovarian reserve: A prospective analysis by menstrual history and ovarian reserve markers
Reh A, Oktem O, Lostritto K, Oktay K. O-227 Impact of breast cancer chemotherapy on ovarian reserve: A prospective analysis by menstrual history and ovarian reserve markers. Fertility And Sterility 2006, 86: s97-s98. DOI: 10.1016/j.fertnstert.2006.07.259.Peer-Reviewed Original Research
2005
Letrozole and tamoxifen as safer ovarian stimulants in women undergoing embryo cryopreservation for fertility preservation before breast cancer chemotherapy: A prospective controlled trial
Oktay K, Libertella N, Buyuk E, Lostritto K, Vickers A, Akar M. Letrozole and tamoxifen as safer ovarian stimulants in women undergoing embryo cryopreservation for fertility preservation before breast cancer chemotherapy: A prospective controlled trial. Journal Of Clinical Oncology 2005, 23: 539-539. DOI: 10.1200/jco.2005.23.16_suppl.539.Peer-Reviewed Original Research